RecruitingNot ApplicableNCT05553899

Utility of PET-MRI in Surveillance of Paediatric Brain Tumours

Utility of PET-MRI in Post-treatment Surveillance of Paediatric Brain Tumours: a Pilot Study


Sponsor

Sheffield Children's NHS Foundation Trust

Enrollment

5 participants

Start Date

Feb 28, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a pilot project to explore the utility of PET-MRI in the post-treatment surveillance of high-grade gliomas or medulloblastomas in children in our institution.


Eligibility

Min Age: 8 YearsMax Age: 18 Years

Inclusion Criteria4

  • Have a presumptive or histologically confirmed diagnosis of a malignant brain tumour requiring treatment
  • Diagnostic uncertainty about tumour recurrence post-treatment based on conventional MR imaging in the opinion of the MDT
  • Have a life expectancy of at least three months
  • Able to comply with an MRI scan without a general anaesthetic

Exclusion Criteria5

  • Unable to comply with an MRI scan without a general anaesthetic
  • Diabetes or other causes of hyperglycaemia
  • Pregnancy
  • Patient body habitus above scanner dimensions
  • Standard contra-indication to MRI (eg. pacemaker, non-compatible metallic implants, altered renal function)

Interventions

RADIATIONPET-MRI

magnetic resonance imaging with positron emission tomography scanning using the tracer 18F-FDG


Locations(1)

Sheffield Children's Hospital

Sheffield, South Yorkshire, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05553899


Related Trials